| Sources | Names Used |
|---|---|
| GDSC1000 | Tivozanib |
| CTRPv2 | tivozanib |
| PharmacoGx | tivozanib |
| Database | Identifier |
|---|---|
| Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
| Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
| Pubchem: | 9911830 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAS2R5 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | FIBIN | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | MAN2A2 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | GOLGA8Q | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | PRRX1 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | HBQ1 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | CDT1 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-07 |
| mRNA | OSCAR | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
| mRNA | POU2AF1 | CTRPv2 | pan-cancer | AAC | -0.2 | 9e-07 |
| mRNA | LAIR1 | GDSC1000 | pan-cancer | AAC | 0.22 | 9e-07 |
